Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?
- PMID: 32835250
- PMCID: PMC7279727
- DOI: 10.1016/S2665-9913(20)30175-2
Are treat-to-target and dose tapering strategies for rheumatoid arthritis possible during the COVID-19 pandemic?
Similar articles
-
[Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission].Rev Med Interne. 2017 Apr;38(4):256-263. doi: 10.1016/j.revmed.2016.12.014. Epub 2017 Feb 1. Rev Med Interne. 2017. PMID: 28161110 Review. French.
-
Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.Clin Rheumatol. 2017 Jan;36(1):1-8. doi: 10.1007/s10067-016-3490-8. Epub 2016 Nov 28. Clin Rheumatol. 2017. PMID: 27896522 Review.
-
Biological tapering and sonographic flare in rheumatoid arthritis.J Investig Med. 2018 Feb;66(2):325-328. doi: 10.1136/jim-2017-000558. Epub 2017 Sep 20. J Investig Med. 2018. PMID: 28935637 Free PMC article.
-
Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA).BMJ Open. 2018 Feb 28;8(2):e019007. doi: 10.1136/bmjopen-2017-019007. BMJ Open. 2018. PMID: 29490959 Free PMC article. Clinical Trial.
-
Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study.Scand J Rheumatol. 2019 Nov;48(6):439-447. doi: 10.1080/03009742.2019.1613674. Epub 2019 Jun 21. Scand J Rheumatol. 2019. PMID: 31220991
Cited by
-
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.Rheumatology (Oxford). 2022 Feb 2;61(2):787-793. doi: 10.1093/rheumatology/keab403. Rheumatology (Oxford). 2022. PMID: 33944915 Free PMC article.
References
-
- Schipper LG, Vermeer M, Kuper HH. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis. 2012;71:845–850. - PubMed
-
- Ramiro S, Landewé RBM, van der Heijde D. Is treat-to-target really working in rheumatoid arthritis? A longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM) Ann Rheum Dis. 2020;79:453–459. - PubMed
-
- Sundin U, Aga A-B, Skare Ø. Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis. Rheumatology (Oxford) 2020 - PubMed
LinkOut - more resources
Full Text Sources